![Francesco DeRubertis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francesco DeRubertis
Director/Board Member at Palladio Biosciences, Inc.
Francesco DeRubertis active positions
Companies | Position | Start | End |
---|---|---|---|
Palladio Biosciences, Inc.
![]() Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Director/Board Member | - | - |
Career history of Francesco DeRubertis
Statistics
International
United States | 2 |
Operational
Director/Board Member | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Palladio Biosciences, Inc.
![]() Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Health Technology |
- Stock Market
- Insiders
- Francesco DeRubertis
- Experience